Mikko Niemi

3 ta ish

University of Helsinki

1. Lipid-lowering response to statins is affected by CYP3A5 polymorphism

   Kari T. Kivistö, Mikko Niemi, Elke Schaeffeler +6

   Maqola20044 iqtibos

   ABIABI:AkademIndex/2026.other.568866

2. SLCO1B1 polymorphism markedly affects the pharmacokinetics of simvastatin acid

   Marja K. Pasanen, Mikko Neuvonen, Pertti J. Neuvonen +1

   Maqola20063 iqtibos

   ABIABI:AkademIndex/2026.other.568899

3. ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin

   Jenni E. Keskitalo, Oliver Zolk, Martin F. Fromm +3

   Maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.697513